ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

ClinicalTrials.gov ID: NCT05844982

Public ClinicalTrials.gov record NCT05844982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 4:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy

Study identification

NCT ID
NCT05844982
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jaeb Center for Health Research
Other
Enrollment
600 participants

Conditions and interventions

Interventions

  • Faricimab Drug
  • fluocinolone acetonide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 20, 2023
Primary completion
Dec 25, 2029
Completion
Dec 25, 2029
Last update posted
Jan 28, 2026

2023 – 2029

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
21
Facility City State ZIP Site status
Byers Eye Institute at Stanford University Palo Alto California 94303 Recruiting
Retina Consultants Manchester Connecticut 06042 Recruiting
Retina Associates of Florida, LLC Tampa Florida 33609 Recruiting
Northwestern Memorial Group Chicago Illinois 60611 Recruiting
IL Eye and Ear Infirmary-University of Illinois at Chicago Chicago Illinois 60612 Recruiting
Midwest Eye Institute Indianapolis Indiana 46290 Recruiting
University of Iowa Department of Ophthalmology and Visual Sciences Iowa City Iowa 52242 Recruiting
Foundation for Vision Research and Retina Specialists of Michigan, P.C. Grand Rapids Michigan 49546 Recruiting
Associated Retinal Consultants, P.C. Royal Oak Michigan 48073 Recruiting
Mayo Clinic Rochester Minnesota 55905 Recruiting
Retina Research Institute, LLC St Louis Missouri 63128 Recruiting
The Cleveland Clinic Foundation DBA Cleveland Clinic Lerner College of Medicine Celveland Ohio 44120 Recruiting
Oregon Health & Science University Portland Oregon 97239 Recruiting
Retina-Vitreous Consultants, Inc. Monroeville Pennsylvania 15146 Recruiting
Wills Eye Hospital Philadelphia Pennsylvania 19107 Recruiting
Pittsburgh Clinical Trial Consortium Sewickley Pennsylvania 15143 Recruiting
Retina Consultants of Carolina, PA Greenville South Carolina 29605 Recruiting
Tennessee Retina, PC Nashville Tennessee 37203 Recruiting
Retina Consultants of Texas, PA Bellaire Texas 77401 Recruiting
UT Southwestern Medical Center Dallas Texas 75390 Recruiting
Texas Retina Associates Lubbock Texas 79424 Recruiting
The Board of Regents of the University of Wisconsin System Madison Wisconsin 53705 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05844982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05844982 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →